% Expired Patents = 16.7

CIPO Patents = 1

EPO Patents = 7

Forward Citations = 65

Loading Chart...

13 inventors (with patents filed for the assignee):

Heribert Bohlen (5 out of 5 patents)

Eugen Kolossov (3 out of 3 patents)

Andreas Ehlich (3 out of 3 patents)

4. Silke Schwengberg (3 out of 3 patents)

5. Ralf Kettenhofen (2 out of 3 patents)

6. Kristina Jönsson (2 out of 2 patents)

7. Jürgen Hescheler (2 out of 3 patents)

8. Leo Fink (1 out of 1 patent)

9. Melanie Scholz (1 out of 1 patent)

10. Bernd Fleischmann (1 out of 2 patents)

11. Wilhelm Röll (1 out of 1 patent)

12. Jessica Königsmann (1 out of 1 patent)

13. Isabella Kopp (1 out of 1 patent)

14. Kristina Tressat (0 patent)

15. Jurgen Hescheler (0 patent)

6 patents: Sort by Forward Citations

1. 9945840 - Non-invasive, in vitro functional tissue assay systems (2018-04-17),

2. 9726662 - Assay for drug discovery based on in vitro differentiated cells (2017-08-08),

3. 9321997 - Tissue modeling in embryonic stem (ES) cell system (2016-04-26),

4. 8318488 - Assay for drug discovery based on in vitro differentiated cells (2012-11-27),

5. 8148152 - Method for the preparation of embryoid bodies (EBs) and uses thereof (2012-04-03),

6. 7105344 - Fluorescent proteins as cell-type specific reporters (2006-09-12),

Company Overview

Axiogenesis AG is a leading provider of high-quality stem cell-derived models for drug discovery, safety pharmacology, and regenerative medicine. Their innovative technology allows for the creation of human-induced pluripotent stem cell (iPSC) based products for various applications in biomedical research.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#66 in Cologne

#5,403 in Germany

Cologne, Germany

Axiogenesis Ag

Forward Citations = 65

13 inventors:

Heribert Bohlen (5 out of 5 patents)

Eugen Kolossov (3 out of 3 patents)

Andreas Ehlich (3 out of 3 patents)

4. Silke Schwengberg (3 out of 3 patents)

5. Ralf Kettenhofen (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Axiogenesis Ag. Retrieved from https://idiyas.com/company/axiogenesis-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]